Tradestie Institutional Equity Comparison Engine
CYAB vs SNYR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SNYR Overall Edge
SNYR Captures Institutional Edge (3โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Synergy CHC Corp. Common Stock (SNYR) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CYAB trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SNYR at 0.6x Forward P/E and -10.3% operating margin (-32.8% YoY). In options structure, CYAB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SNYR
CYAB N/M vs SNYR 0.6x Fwd P/E
Growth & Margin Winner
SNYR
Op Margin N/A vs -10.3% ยท YoY N/A vs -32.8%
Momentum & Technical Winner
SNYR
1Y -98.3% vs -96.2% ยท 52W Pos 0% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CYAB
US Equity
CYAB
Institutional Equity
$0.06
-3.39% 1D
Market Cap
N/A
1M Return
-56.18%
1Y Return
-98.3%
Forward P/E
N/M
Unified AI Score
48.4 / 100
HOLD
Tech 43.0
Fund 52.0
Flow 50.0
Mom 88.9
SNYR
NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap
$4.1M
1M Return
-16.28%
1Y Return
-96.15%
Forward P/E
0.6x
Unified AI Score
48.9 / 100
HOLD
Tech 55.0
Fund 39.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CYAB -98.3%
SNYR -96.15%
Spread: +0.65 pp (CYAB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CYAB TTM Op. Margin: N/A
SNYR TTM Op. Margin: -10.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYAB vs SNYR. Trailing 12-month operating profitability (CYAB N/A vs SNYR -10.3%) and valuation multiples (CYAB N/M vs SNYR 0.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CYAB | SNYR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $4.1M | Larger Scale | SNYR |
| Trailing P/E Ratio Valuation | N/M | 0.6x | Lower Multiple | SNYR |
| Forward P/E Ratio Valuation | N/M | 0.6x | Lower Multiple | SNYR |
| Revenue Growth (YoY) Growth | N/A | -32.8% | Higher Growth | SNYR |
| Operating Margin (TTM) Profitability | N/A | -10.3% | Higher Margin | SNYR |
| Net Profit Margin Profitability | N/A | -57.0% | Higher Margin | SNYR |
| Return on Equity (ROE) Capital Efficiency | N/A | -361.1% | Higher ROE | SNYR |
| 52-Week Range Position Momentum | 0% ($0โ$6) | 1% ($0โ$3) | Stronger Trend | SNYR |
| Beta / 30D Volatility Risk Regime | 0.45ฮฒ ยท 246% Vol | -0.86ฮฒ ยท 868% Vol | Lower Realized Risk | CYAB |
| Unified Institutional Score Composite Signal | 48.4 / 100 (HOLD) | 48.9 / 100 (HOLD) | Higher Composite | SNYR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CYAB vs SNYR Buy Guide
CYAB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SNYR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CYAB nor SNYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.